Share

May 01, 2012; 78 (18) Articles

Increased risk of epilepsy in biopsy-verified celiac disease

A population-based cohort study

J.F. Ludvigsson, F. Zingone, T. Tomson, A. Ekbom, C. Ciacci
First published April 18, 2012, DOI: https://doi.org/10.1212/WNL.0b013e3182544728
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
226

Share

Article Information

vol. 78 no. 18 1401-1407
DOI: 
https://doi.org/10.1212/WNL.0b013e3182544728
PubMed: 
22517096
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received August 19, 2011
  • Accepted November 28, 2011
  • First Published April 18, 2012.

Article Versions

Copyright & Usage: 
Copyright © 2012 by AAN Enterprises, Inc.

Author Disclosures

    1. J.F. Ludvigsson, MD, PhD,
    2. F. Zingone, MD, PhD,
    3. T. Tomson, MD, PhD,
    4. A. Ekbom, MD, PhD and
    5. C. Ciacci, MD, PhD
  1. J.F. Ludvigsson, MD, PhD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. the Swedish Research Council – Medicine (522-2A09- 195), 2010-2013

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. The Swedish Society of Medicine (2010-2013) The below funders are relevant to this project but it is now more than two years since I received support from them: 2) the Sven Jerring Foundation, 3) the Örebro Society of Medicine, 4) the Karolinska Institutet, 4) Örebro University Hospital, 5) the Clas Groschinsky Foundation, 6) the Juhlin Foundation, 7) the Majblomman Foundation, 8) Uppsala-Örebro Regional Research Council and 9) the Swedish Celiac Society.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. F. Zingone, MD, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. T. Tomson, MD, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. UCB, travel support to congress, speaker honorarium (paid to department); Eisai, Inc., speaker honorarium (paid to department)

    Editorial Boards:

    1. Epilepsia, Associate Editor, 2008-present; Epilepsy Research, Editorial Board, 2007-present; Epileptic Disorders, Editorial Board, 2010-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. As chair of the central project commission of EURAP, an international antiepileptic drugs and pregnancy registry, I have on behalf of the project received research grants from Eisai, GlaxoSmithKline, Johnson & Johnson/Janssen-Cilag, Novartis, Sanofi- Aventis, Pfizer and UCB annually the past two years

    Research Support, Government Entities:

    1. ALF (Stockholm County Council) 2009-2011

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. CURE, 2010

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. A. Ekbom, MD, PhD and
    5. Scientific Advisory Boards:

    1. Centocor; Wyatt

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. AstraZeneca, speaker honoraria

    Editorial Boards:

    1. Scandinavian Journal of Gastroenterology, Editor, 1995-present; International Journal of Colorectal Diseases, Editor, 1999-present; European Journal of Epidemiology, Editor, 2003-present; Journal of Internal Medicine, Editor, 2007-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Stockholm County Council (ALF), LS 1001-0029, PI, 3 yrs

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Swedish Cancer Society

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. C. Ciacci, MD, PhD
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Funds from Regione Campania, Italy 1 year 2009-2010 project ’Porte Aperte alla Celiachia’ for education of GPS on celiac disease

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Pediatrics (J.F.L.), Örebro University Hospital, Örebro; Clinical Epidemiology Unit (J.F.L., A.E.), Department of Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Clinical and Experimental Medicine (F.Z.), Federico II University of Naples, Naples, Italy; Department of Clinical Neuroscience (T.T.), Karolinska Institutet, Stockholm, Sweden; and Department of Gastroenterology (C.C.), University of Salerno, Salerno, Italy.
  1. Correspondence & reprint requests to Dr. Ludvigsson: jonasludvigsson{at}yahoo.com
View Full Text

Article usage

Article usage: April 2012 to April 2022

AbstractFullPdfSource
Apr 20124691014Highwire
May 201214749255Highwire
Jun 20121773111Highwire
Jul 2012108114Highwire
Aug 2012103119Highwire
Sep 20125444Highwire
Oct 20125343Highwire
Nov 20125674Highwire
Dec 20125160Highwire
Jan 201364135Highwire
Feb 20134752Highwire
Mar 20136831Highwire
Apr 20136172Highwire
May 20133265Highwire
Jun 20132641Highwire
Jul 20132812Highwire
Aug 20135911Highwire
Sep 20132641Highwire
Oct 20134134Highwire
Nov 20132723Highwire
Dec 20133654Highwire
Jan 20144472Highwire
Feb 201423108Highwire
Mar 201428127Highwire
Apr 201446238Highwire
May 20143300Highwire
Jun 20141400Highwire
Jul 20142511Highwire
Aug 20141442Highwire
Sep 20142912Highwire
Oct 20144343Highwire
Nov 20142700Highwire
Dec 20142512Highwire
Jan 20152010Highwire
Feb 20151400Highwire
Mar 20152600Highwire
Apr 2015321Highwire
May 20152403Highwire
Jun 20151411Highwire
Jul 20151311Highwire
Aug 20151601Highwire
Sep 20152600Highwire
Oct 20151400Highwire
Nov 20152302Highwire
Dec 20151600Highwire
Jan 20163011Highwire
Feb 20163700Highwire
Mar 20161800Highwire
Apr 20161211Highwire
May 20161200Highwire
Jun 20162900Highwire
Jul 2016921Highwire
Aug 20161810Highwire
Sep 20161500Highwire
Oct 20162700Highwire
Nov 20161700Highwire
Dec 20161600Highwire
Jan 20171211Highwire
Feb 20171400Highwire
Mar 20173212Highwire
Apr 20171700Highwire
May 20172200Highwire
Jun 20171910Highwire
Jul 20171301Highwire
Aug 20171300Highwire
Sep 20171400Highwire
Oct 20175612Highwire
Nov 20172420Highwire
Dec 20173601Highwire
Jan 20183410Highwire
Feb 20183221Highwire
Mar 20184910Highwire
Apr 20182711Highwire
May 20184322Highwire
Jun 20182600Highwire
Jul 20182100Highwire
Aug 20183311Highwire
Sep 20181832Highwire
Oct 20186401Highwire
Nov 20182322Highwire
Dec 20182500Highwire
Jan 20191200Highwire
Feb 20191501Highwire
Mar 20191800Highwire
Apr 20191502Highwire
May 20191311Highwire
Jun 20191311Highwire
Jul 20192400Highwire
Aug 20192301Highwire
Sep 20191700Highwire
Oct 20191800Highwire
Nov 20192030Highwire
Dec 20191811Highwire
Jan 20204310Highwire
Feb 20201611Highwire
Mar 20201000Highwire
Apr 20201200Highwire
May 20201900Highwire
Jun 20202500Highwire
Jul 20201300Highwire
Aug 20202103Highwire
Sep 20201800Highwire
Oct 20202011Highwire
Nov 20202323Highwire
Dec 20202400Highwire
Jan 20214100Highwire
Feb 20214110Highwire
Mar 20213411Highwire
Apr 20214200Highwire
May 20213900Highwire
Jun 20213600Highwire
Jul 20213621Highwire
Aug 20215301Highwire
Sep 20212801Highwire
Oct 20213600Highwire
Nov 20214300Highwire
Dec 20213802Highwire
Jan 20223602Highwire
Feb 20226000Highwire
Mar 20224002Highwire
Apr 20223402Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top

More Online

CME Course

Topics Discussed

Alert Me